Could an Eli Lilly and Co. drug used to treat patients with rheumatoid arthritis work on those suffering from COVID-19?  We get a top Lilly executive’s take on the drug and why the company feels obligated to test it.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Upgrade Now

Big business news. Teeny tiny price. $1/week Upgrade Now

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indiana business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In